Merck Global Health Innovation Fund

Bill Taranto, president of Merck Global Health Innovation Fund, talks about the funding environment and how digital health companies can ensure investment this year.

Digital chronic disease management company Livongo has raised $105 million in new Series E funding, mostly from existing investors.

Baltimore, Maryland-based WellDoc has raised $22 million in a round led by Samsung Ventures and Merck Global Health Innovation (GHI) Fund with participation from Adage Capital Management, Excel Venture Management, Alexandria Venture Investments and Hudson River Capital Partners.

Wesley Chapel, Florida-based care coordination platform CareSync raised $18 million in a round from the Merck Global Health Innovation Fund (Merck GHI), Greycroft Partners, and Harbert Venture Partners, with participation from existing investors Tullis Health Investors, Clearwell Group, CDH Solutions, and CareSync CEO Travis Bond.

Vancouver-based Ayogo has raised $2.

While digital health funding in general has been growing enormously year-to-year, so too have strategic corporate investments, according to a new report by CB Insights.

Healthcare treatment comparison tool WiserTogether raised $9 million in a round led by Martin Ventures and Merck Global Health Innovation Fund with participation from WiserTogether CEO Shub Debgupt and existing investors Grotech Ventures, Harbert Venture Partners, 7Wire Ventures, and Blue Heron Capital.

Remote cardiac monitoring company eCardio has agreed to merge with wearable, remote monitoring device maker Preventice.